Discover

LGVN
Longeveron Inc.
0.73
2 x 0.53
2 x 0.92
bid
ask
+
0.03
3.71%
2 @ 04:00 PM
0.73 +0.00 (0.27%)
Ytd44.09%
1y-43.04%
0.71
day range
0.79
0.47
52 week range
1.80
Open0.72Prev Close0.70Low0.71High0.79Mkt Cap23.04M
Vol611.65KAvg Vol464.44KEPS-1.14P/EN/AForward P/E-1.16
Beta0.35Short Ratio2.03Inst. Own3.34%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg0.80200-d Avg0.741yr Est8.88
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-122024-09-0.53-0.340.1935.85%
2024-08-142024-06-1.03-1.83-0.8-77.67%
2024-08-142024-06-1.03N/AN/AN/A
2024-05-142024-03-2.01-1.610.419.90%
2024-05-142024-03-2.01N/AN/AN/A
2024-02-272023-12-2.1-2.5-0.4-19.05%
Upgrade / Downgrade
DateFirmActionFromTo
2024-12-05Roth MKMUpgradeBuy
2024-11-25HC Wainwright & Co.UpgradeBuyBuy
2024-11-04HC Wainwright & Co.UpgradeBuyBuy
2024-09-04HC Wainwright & Co.UpgradeBuyBuy
2024-08-27Maxim GroupUpgradeBuyBuy
2024-08-15HC Wainwright & Co.UpgradeBuyBuy
Profile
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Insider Holder
DateNameRelationQuantityDescription
2024-08-14AGAFONOVA NATALIYAOfficer163.13KStock Award(Grant)
2024-12-01BALUCH KHOSODirector23.75KSale
2024-08-14HARE JOSHUA MOfficer, Director and Beneficial Owner727.05KStock Award(Grant)
2024-08-14HARE NEIL EDirector30.25KStock Award(Grant)
2024-08-14HASHAD MOHAMED WA'EL AHMEDChief Executive Officer90.37KStock Award(Grant)
2024-05-09KENDER RICHARD NDirector16.00KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Geode Capital Management, LLC128.95K228.24K0.97%
2024-09-29Vanguard Group Inc44.98K79.62K0.34%
2024-09-29Capital Investment Advisory Services, LLC26.53K46.95K0.20%
2024-09-29State Street Corporation15.18K26.87K0.11%
2024-09-29Creative Planning11.20K19.82K0.08%
2024-09-29Blackrock Inc.10.02K17.73K0.08%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-10-30Fidelity Extended Market Index Fund72.20K127.79K0.54%
2024-09-29Vanguard Extended Market Index Fund44.98K79.62K0.34%
2024-10-30Fidelity Total Market Index Fund24.14K42.72K0.18%
2024-10-30Fidelity Series Total Market Index Fund17.09K30.24K0.13%
2024-10-30Fidelity NASDAQ Composite Index Fund3.57K6.32K0.03%
Split
SplitDate
1 : 102024-03-27